Examining exposure misclassification of oral bisphosphonate therapy and the associated fracture risk: a cohort study
Burden AM, Gruneir A, Paterson JM, Cadarette SM. Adv Pharmacoepidemiol Drug Saf. 2015; 4:4.
Burden AM, Gruneir A, Paterson JM, Cadarette SM. Adv Pharmacoepidemiol Drug Saf. 2015; 4:4.
Ouellette-Kuntz H, Martin L, McKenzie K. Int Rev Res Dev Disabil. 2015; 48:151-94.
Tanuseputro P, Wodchis WP, Fowler R, Walker P, Bai YQ, Bronskill SE, Manuel D. PLoS One. 2015; 10(3):e0121759.
Gruneir A, Kwong J, Campitelli MA, Newman A, Anderson G, Rochon P, Mor V. Am J Public Health. 2014; 104(2):e141-7. Epub 2013 Dec 12.
Gruneir A, Forrester J, Camacho X, Gill SS, Bronskill SE. BMC Geriatr. 2013; 13:48. Epub 2013 May 16.
Daneman N, Gruneir A, Bronskill SE, Newman A, Fischer HD, Rochon PA, Anderson GM, Bell CM. JAMA Intern Med. 2013; 173(8):673-82.
Gruneir A. Healthc Q. 2013; 16(2):13-5.
Steele LS, Durbin A, Sibley LM, Glazier R. Open Med. 2013; 7(1):e9-20. Epub 2013 Feb 12.
Lam JM, Anderson GM, Austin PC, Bronskill SE. Can Fam Physician. 2012; 58(11):1241-8.
Bell CM, Brener SS, Comrie R, Anderson GM, Bronskill SE. Drugs Aging. 2012; 29(4):319-27.